Edwards Lifesciences Corp - Common Stock (EW) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
EW on NYSE
Shares outstanding
590,231,680
Price per share
$85.25
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
491,050,096
Total reported value
$38,162,022,380
% of total 13F portfolios
0.02%
Share change
-10,615,644
Value change
-$832,501,188
Number of holders
1,237
Price from insider filings
$85.25
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Edwards Lifesciences Corp - Common Stock (EW) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 12% $4,718,923,153 69,131,602 The Vanguard Group 31 Dec 2024
BlackRock, Inc. 7.5% $3,442,673,832 44,267,376 BlackRock, Inc. 30 Sep 2025
WELLINGTON MANAGEMENT GROUP LLP 3.4% $1,485,400,106 19,826,483 Wellington Management Group LLP 30 Jun 2025

As of 30 Sep 2025, 1,237 institutional investors reported holding 491,050,096 shares of Edwards Lifesciences Corp - Common Stock (EW). This represents 83% of the company’s total 590,231,680 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Edwards Lifesciences Corp - Common Stock (EW) together control 58% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 12% 70,363,210 +0.52% 0.08% $5,472,146,840
BlackRock, Inc. 9.2% 54,294,173 -2.4% 0.07% $4,222,457,858
STATE STREET CORP 4.3% 25,619,632 -0.06% 0.07% $1,992,438,781
JPMORGAN CHASE & CO 4.2% 25,058,526 -6.4% 0.12% $1,948,810,981
WELLINGTON MANAGEMENT GROUP LLP 3.5% 20,804,416 +4.9% 0.28% $1,617,959,432
Bank of New York Mellon Corp 3.2% 19,010,227 +8.1% 0.27% $1,478,425,326
FMR LLC 2.5% 14,578,812 +477% 0.06% $1,133,794,239
JENNISON ASSOCIATES LLC 2.4% 13,958,774 +20% 0.63% $1,085,573,836
GEODE CAPITAL MANAGEMENT, LLC 2.2% 12,837,145 +0.9% 0.06% $993,485,949
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main 1.6% 9,240,197 +1.2% 0.65% $718,609,710
Ninety One UK Ltd 1.3% 7,908,572 +14% 1.3% $615,049,645
BROWN ADVISORY INC 1.2% 7,357,788 +0.62% 0.74% $572,215,191
MORGAN STANLEY 1.1% 6,509,349 -13% 0.03% $506,232,319
DEUTSCHE BANK AG\ 1% 6,163,645 +2.5% 0.16% $479,346,670
NORTHERN TRUST CORP 1% 6,040,645 -1.2% 0.06% $469,780,962
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC 0.95% 5,584,646 +278% 0.09% $434,317,919
WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST 0.81% 4,800,000 0% 4.1% $373,296,000
Holocene Advisors, LP 0.8% 4,746,694 +0.91% 0.85% $369,150,392
Nuveen, LLC 0.77% 4,541,426 -1.4% 0.09% $353,186,700
NORDEA INVESTMENT MANAGEMENT AB 0.72% 4,246,964 -2.5% 0.29% $328,545,134
CITADEL ADVISORS LLC 0.72% 4,234,570 -67% 0.26% $329,322,509
Legal & General Group Plc 0.7% 4,106,769 -2.8% 0.07% $319,383,421
DIMENSIONAL FUND ADVISORS LP 0.62% 3,683,748 +9.1% 0.06% $286,469,664
Invesco Ltd. 0.6% 3,570,216 +9% 0.04% $277,655,736
MARSHALL WACE, LLP 0.6% 3,566,499 -48% 0.3% $277,366,628

Institutional Holders of Edwards Lifesciences Corp - Common Stock (EW) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 17,138,603 $1,456,817,692 +$35,591,032 $85.25 221
2025 Q3 491,050,096 $38,162,022,380 -$832,501,188 $77.77 1,237
2025 Q2 501,621,113 $39,209,886,931 +$342,426,550 $78.21 1,244
2025 Q1 498,054,061 $36,079,617,248 -$471,245,671 $72.48 1,185
2024 Q4 501,653,574 $37,135,145,296 +$1,963,226,750 $74.03 1,203
2024 Q3 468,729,818 $30,943,227,670 -$2,214,683,590 $65.99 1,169
2024 Q2 491,173,308 $45,361,996,305 +$1,463,449,963 $92.37 1,268
2024 Q1 477,520,515 $45,553,061,697 +$211,843,074 $95.56 1,258
2023 Q4 3,673,597 $280,172,006 -$40,490,016 $76.25 21
2023 Q3 480,930,229 $33,338,417,598 -$194,900,449 $69.28 1,185
2023 Q2 482,287,996 $45,402,624,302 -$1,069,739,915 $94.33 1,243
2023 Q1 492,263,210 $40,724,103,562 -$939,625,497 $82.73 1,206
2022 Q4 484,355,330 $36,160,434,866 +$96,272,435 $74.61 1,188
2022 Q3 494,387,319 $40,894,812,414 -$10,602,455 $82.63 1,204
2022 Q2 506,515,100 $48,079,635,422 +$244,983,489 $95.09 1,230
2022 Q1 505,144,922 $59,407,620,835 -$978,866,791 $117.72 1,279
2021 Q4 512,808,609 $66,363,093,555 -$139,620,898 $129.55 1,289
2021 Q3 511,360,611 $57,886,499,978 +$233,951,076 $113.21 1,206
2021 Q2 509,481,545 $52,761,611,830 +$552,946,630 $103.57 1,162
2021 Q1 505,527,182 $42,290,211,898 -$433,292,067 $83.64 1,115
2020 Q4 504,959,120 $46,041,652,212 +$38,272,491 $91.23 1,128
2020 Q3 513,616,906 $40,971,555,140 +$885,794,911 $79.82 1,059
2020 Q2 499,471,363 $34,544,641,771 +$22,700,986,606 $69.11 1,008
2020 Q1 167,092,736 $31,520,797,769 -$685,863,967 $188.62 975
2019 Q4 171,480,388 $39,984,732,179 +$46,227,554 $233.29 1,061
2019 Q3 171,518,831 $37,709,508,677 -$177,468,085 $219.91 945
2019 Q2 172,698,470 $31,904,145,015 +$968,811,426 $184.74 900
2019 Q1 175,125,346 $33,499,001,587 -$277,350,417 $191.33 908
2018 Q4 176,523,077 $27,035,640,674 +$77,310,542 $153.17 857
2018 Q3 175,290,563 $30,507,553,650 +$112,142,569 $174.10 841
2018 Q2 175,072,201 $25,483,824,485 +$595,019,608 $145.57 826
2018 Q1 174,022,929 $24,269,748,042 +$71,831,201 $139.52 800
2017 Q4 171,351,459 $19,314,706,235 -$327,402,087 $112.71 760
2017 Q3 176,565,779 $19,299,757,559 +$155,016,794 $109.31 733
2017 Q2 175,463,081 $20,744,042,244 -$7,808,434 $118.24 711
2017 Q1 175,989,137 $16,556,447,229 +$723,645,713 $94.07 676
2016 Q4 178,207,029 $16,694,643,010 -$384,147,304 $93.70 663
2016 Q3 179,150,369 $21,579,770,911 +$89,320,468 $120.56 683
2016 Q2 177,811,120 $17,732,135,511 +$148,889,857 $99.73 678
2016 Q1 175,646,398 $15,492,105,147 -$95,187,389 $88.21 635
2015 Q4 182,669,386 $14,426,687,075 +$7,511,712,374 $78.98 590
2015 Q3 87,881,497 $12,493,551,323 +$382,492,907 $142.17 559
2015 Q2 83,343,863 $11,870,393,386 -$841,749,385 $142.43 570
2015 Q1 90,806,811 $12,927,928,810 -$25,259,550 $142.46 566
2014 Q4 91,808,512 $11,695,853,623 -$78,854,430 $127.38 552
2014 Q3 91,202,442 $9,316,631,680 -$117,820,801 $102.15 480
2014 Q2 93,316,348 $8,010,196,007 -$353,118,557 $85.84 423
2014 Q1 97,604,601 $7,243,435,163 -$57,627,370 $74.17 402